Skip to main content
Paul Armistead, MD, Oncology, Chapel Hill, NC

PaulMichaelArmisteadMDPhD

Oncology Chapel Hill, NC

Hematologic Oncology

Associate Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine

Dr. Armistead is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Armistead's full profile

Already have an account?

  • Office

    101 Manning Dr
    Chapel Hill, NC 27599
    Phone+1 919-966-4131

Summary

  • Stem cell transplant and cellular therapy

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 2002

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2008 - 2025
  • TX State Medical License
    TX State Medical License 2005 - 2010
  • MA State Medical License
    MA State Medical License 2004 - 2005
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Age-Associated Changes in the Respiratory Epithelial Response to Influenza Infection
    Paul Armistead, MD, The Journals of Gerontology, Orlando, FL, 12/7/2019

Press Mentions

  • Could Baking Soda Fight Leukemia Relapse After Stem Cell Transplant?
    Could Baking Soda Fight Leukemia Relapse After Stem Cell Transplant?January 5th, 2021
  • UNC Lineberger Awards $1.35M for Cancer Research
    UNC Lineberger Awards $1.35M for Cancer ResearchFebruary 11th, 2019
  • Researchers Lay the Foundation for Personalized Immune Treatments for Leukemia
    Researchers Lay the Foundation for Personalized Immune Treatments for LeukemiaAugust 31st, 2018
  • Join now to see all